Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.
Furuzawa-Carballeda J, Lima G, Alberú J, Palafox D, Uribe-Uribe N, Morales-Buenrostro LE, Reyes Acevedo R, Mondragón G, Chevaile A, Llorente L. Furuzawa-Carballeda J, et al. Among authors: lima g. Clin Exp Immunol. 2012 Feb;167(2):330-7. doi: 10.1111/j.1365-2249.2011.04504.x. Clin Exp Immunol. 2012. PMID: 22236010 Free PMC article.
Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans.
Fragoso JM, Delgadillo H, Llorente L, Chuquiure E, Juárez-Cedillo T, Vallejo M, Lima G, Furuzawa-Carballeda J, Peña-Duque MA, Martínez-Ríos MA, Vargas-Alarcón G. Fragoso JM, et al. Among authors: lima g. Immunol Lett. 2010 Oct 30;133(2):106-11. doi: 10.1016/j.imlet.2010.08.003. Epub 2010 Aug 13. Immunol Lett. 2010. PMID: 20709104
High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment.
Furuzawa-Carballeda J, Lima G, Uribe-Uribe N, Avila-Casado C, Mancilla E, Morales-Buenrostro LE, Pérez-Garrido J, Pérez M, Cárdenas G, Llorente L, Alberú J. Furuzawa-Carballeda J, et al. Among authors: lima g. Transplant Proc. 2010 Nov;42(9):3489-96. doi: 10.1016/j.transproceed.2010.08.037. Transplant Proc. 2010. PMID: 21094802 Clinical Trial.
The T29C polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with genetic susceptibility to acute coronary syndrome in Mexican patients.
Fragoso JM, Martínez-Ríos MA, Alvarez-León E, Vallejo M, Peña-Duque MA, Posadas-Sánchez R, Posadas-Romero C, Furuzawa-Carballeda J, Lima G, Llorente L, Vargas-Alarcón G. Fragoso JM, et al. Among authors: lima g. Cytokine. 2012 Jun;58(3):380-3. doi: 10.1016/j.cyto.2012.03.004. Epub 2012 Mar 31. Cytokine. 2012. PMID: 22465044
Polymerized-type I collagen downregulates inflammation and improves clinical outcomes in patients with symptomatic knee osteoarthritis following arthroscopic lavage: a randomized, double-blind, and placebo-controlled clinical trial.
Furuzawa-Carballeda J, Lima G, Llorente L, Nuñez-Álvarez C, Ruiz-Ordaz BH, Echevarría-Zuno S, Hernández-Cuevas V. Furuzawa-Carballeda J, et al. Among authors: lima g. ScientificWorldJournal. 2012;2012:342854. doi: 10.1100/2012/342854. Epub 2012 Apr 1. ScientificWorldJournal. 2012. PMID: 22545014 Free PMC article. Clinical Trial.
Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized scleroderma.
Furuzawa-Carballeda J, Ortíz-Ávalos M, Lima G, Jurado-Santa Cruz F, Llorente L. Furuzawa-Carballeda J, et al. Among authors: lima g. Clin Exp Dermatol. 2012 Aug;37(6):599-609. doi: 10.1111/j.1365-2230.2012.04385.x. Epub 2012 Jun 25. Clin Exp Dermatol. 2012. PMID: 22731679 Clinical Trial.
1,367 results